NAD

NAD Recommends Telebrands Discontinue Certain Claims for ‘Atomic Beam’ Flashlights; Advertiser to Appeal NAD’s BOGO Finding

New York, NY – July 19, 2018 – The National Advertising Division has recommended that Telebrands, Corp., discontinue certain advertising claims for the company’s Atomic Beam flashlights, including claims that they are “40 times brighter” and more durable than ordinary flashlights and are equipped with features that ordinary flashlights do not provide. NAD noted that nothing in its decision precludes the advertiser from making comparative claims regarding the Atomic Beam and competing flashlights provided that the claims are supported by comparative testing and clearly disclose the...

Read More

NAD Recommends Tru Derma Discontinue Claims, Testimonials for Mangodrin Supplement Following CRN Challenge

New York, NY – July 18, 2018 – The National Advertising Division has recommended that Tru Derma, LLC, discontinue advertising claims challenged by the Council for Responsible Nutrition, for the company’s Mangodrin XTREME Formula and Mangodrin Stimulant Free dietary supplements. NAD is an investigative unit of the advertising industry’s self-regulatory system. It is administered by the Council of Better Business Bureaus. Claims at issue included: “Lose Up To 28 lbs. In just 10 Weeks” “Increase Energy & Mental Focus” “See Results In 14 Days” “Control Appetite &...

Read More

NAD Recommends Chattem Discontinue ‘Twice As Fast’ Claim for Xyzal Following Challenge from Claritin Maker Bayer HealthCare

New York, NY – July 18, 2018 – The National Advertising Division has recommended that Chattem, Inc., discontinue claims that the company’s Xyzal Allergy 24 HR product works “Twice as fast as Claritin” and provides “relief that starts at hour 1 instead of hour 2.” NAD is an investigative unit of the advertising industry’s self-regulatory system. It is administered by the Council of Better Business Bureaus. The claims at issue were challenged by Bayer HealthCare LLC, maker of Claritin. Both Bayer’s Claritin and Chattem’s Xyzal are over-the-counter oral antihistamines...

Read More

NAD Recommends Comcast Discontinue Express, Implied Claims That AT&T ‘Deceives’ Customers, Comcast to Appeal

New York, NY – July 17, 2018 – The National Advertising Division has recommended that Comcast Cable Communications, LLC, discontinue the advertising claim, express or implied, that AT&T deceives potential customers concerning the speed or reliability of its internet service, as well as the claim that Comcast offers the most reliable network. NAD also determined, however, that Comcast had substantiated certain claims regarding the availability of AT&T’s fiber network and certain advertised speeds, but recommended  Comcast modify its advertising to avoid conveying the message,...

Read More

Laura Brett

Laura Brett Director Laura Brett  joined NAD in April 2012. Prior to joining NAD, Laura specialized in litigation matters in her own private practice and at Willkie Farr & Gallagher. Laura litigated a wide variety of cases in state and federal courts, including, securities fraud cases, accounting and actuarial liability matters, trademark related breach of contract claims, as well as cases involving family law, political asylum, and intellectual property. Laura is experienced working in alternative dispute resolution forums including representing clients in mediation and arbitration....

Read More

Eric Unis

Eric Unis Staff Attorney Eric Unis joined NAD as a Staff Attorney in December 2017. Prior to joining NAD, Eric worked as an attorney at Troutman Sanders LLP. In over fifteen years of private practice representing clients in a wide range of industries, Eric focused on complex commercial litigation, consumer class actions, government investigations, consumer product safety issues, and advertising and marketing law. Eric has also worked on numerous pro bono matters on behalf of immigrant children. Eric has a B.A. from New York University with a double major in Politics and History and received...

Read More